John M. Strasswimmer

Dermatology

515 E 1st St
Salida, CO 81201

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Acute mucocutaneous syndrome and hemophagocytic lymphohistiocytosis following COVID-19 with prominent emperipolesis.

Acute mucocutaneous syndrome and hemophagocytic lymphohistiocytosis following COVID-19 with prominent emperipolesis.

Journal: JAAD case reports

Published: July 25, 2026

HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study.

HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 16, 2026

HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study.

HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 01, 2026

Barbed suture-assisted high-tension cutaneous closure: Brief report of 493 surgical defects.

Barbed suture-assisted high-tension cutaneous closure: Brief report of 493 surgical defects.

Journal: Journal of the American Academy of Dermatology

Published: March 24, 2026

Melanoma outcome disparities in minority populations and the need for inclusive clinical trials for the benefit of all.

Melanoma outcome disparities in minority populations and the need for inclusive clinical trials for the benefit of all.

Journal: Journal of the American Academy of Dermatology

Published: March 04, 2026

Neoadjuvant cemiplimab to facilitate Mohs micrographic surgery tumor extirpation and reduce surgical morbidity.

Neoadjuvant cemiplimab to facilitate Mohs micrographic surgery tumor extirpation and reduce surgical morbidity.

Journal: JAAD international

Published: December 01, 2025

Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III study.

Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III study.

Journal: Journal of the American Academy of Dermatology

Published: May 22, 2025

CASE (CemiplimAb-rwlc Survivorship and Epidemiology): a study in advanced basal cell carcinoma.

CASE (CemiplimAb-rwlc Survivorship and Epidemiology): a study in advanced basal cell carcinoma.

Journal: Future oncology (London, England)

Published: January 11, 2025

Twelve-year continuous therapy with vismodegib for advanced basal cell carcinoma: Tolerability and partial reversibility of adverse events.

Twelve-year continuous therapy with vismodegib for advanced basal cell carcinoma: Tolerability and partial reversibility of adverse events.

Journal: JAAD case reports

Published: May 14, 2024

Knowledge, Attitudes, and Perceptions of Skin Cancer Clinical Trials in the Hispanic Population.

Knowledge, Attitudes, and Perceptions of Skin Cancer Clinical Trials in the Hispanic Population.

Journal: Cureus

Published: February 06, 2024

How We Do It: Articaine for Infiltrative Anesthesia.

How We Do It: Articaine for Infiltrative Anesthesia.

Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]

Published: September 08, 2023

Optimizing the pharmacokinetics of sonidegib in small bowel syndrome and advanced basal cell carcinoma: Our solution.

Optimizing the pharmacokinetics of sonidegib in small bowel syndrome and advanced basal cell carcinoma: Our solution.

Journal: JAAD case reports

Published: July 31, 2023

Showing 1-12 of 35

Last Updated: 09/26/2026